Skip to main content
SpringerLink
Log in

Aqueous Shunt for Neovascular Glaucoma

  • Chapter
  • First Online:
Neovascular Glaucoma

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 237 Accesses

Abstract

Aqueous shunts are considered the first-line intraocular pressure-lowering surgery in the setting of neovascular glaucoma. Although aqueous shunts differ in size, material composition, and the presence or absence of a valve, they share a common design that consists of a silicone tube that shunts aqueous humor to an endplate, creating an overlying equatorial fornix-based capsule. In the setting of neovascular glaucoma, the advantages of an aqueous shunt over trabeculectomy include (1) the presence of a permanent sclerostomy (the tube); (2) aqueous drainage to the equatorial region where the potential for conjunctival scarring may be less than the limbal conjunctiva; (3) a predetermined capsular area (the endplate). This chapter will discuss the mechanisms, surgical techniques, outcomes, and complications of aqueous shunt surgery in the setting of neovascular glaucoma. Implant types described in this section include the Molteno, Krupin, Schocket, Baerveldt, Ahmed glaucoma valve, and the Ahmed ClearPath. Additionally, this chapter discusses outcomes of combined retinal treatment and aqueous shunt surgery and secondary treatment options if aqueous shunt failure occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Change history

  • 12 January 2023

    The title of Chapter 17 was printed incorrectly as “Aqueous Shunt for Neovascular Glaucoma Implant”, which has been corrected as “Aqueous Shunt for Neovascular Glaucoma” in the Table of Contents, chapter opening page, and running heads throughout the chapter.

References

  1. Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma. Etiologic considerations. Ophthalmology. 1984;91(4):315–20.

    Article  CAS  Google Scholar 

  2. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108(10):1767–76. quiz1777, 1800

    Article  CAS  Google Scholar 

  3. Sidoti PA, Dunphy TR, Baerveldt G, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995;102(7):1107–18.

    Article  CAS  Google Scholar 

  4. Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol. 2012;57(6):530–50.

    Article  Google Scholar 

  5. Hyung SM, Kim SK. Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean J Ophthalmol. 2001;15(2):98–106.

    Article  CAS  Google Scholar 

  6. Tsai JC, Feuer WJ, Parrish RK, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology. 1995;102(6):887–92. discussion 892−883.

    Google Scholar 

  7. Delgado MF, Dickens CJ, Iwach AG, et al. Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma. Ophthalmology. 2003;110(5):895–9.

    Article  Google Scholar 

  8. Eid TE, Katz LJ, Spaeth GL, Augsburger JJ. Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmology. 1997;104(10):1692–700.

    Article  CAS  Google Scholar 

  9. Netland PA. The Ahmed glaucoma valve in neovascular glaucoma (an AOS thesis). Trans Am Ophthalmol Soc. 2009;107:325–42.

    Google Scholar 

  10. Xie Z, Liu H, Du M, et al. Efficacy of Ahmed glaucoma valve implantation on neovascular glaucoma. Int J Med Sci. 2019;16(10):1371–6.

    Article  Google Scholar 

  11. Kolomeyer AM, Seery CW, Emami-Naeimi P, Zarbin MA, Fechtner RD, Bhagat N. Combined pars plana vitrectomy and pars plana Baerveldt tube placement in eyes with neovascular glaucoma. Retina. 2015;35(1):17–28.

    Article  Google Scholar 

  12. Arora KS, Robin AL, Corcoran KJ, Corcoran SL, Ramulu PY. Use of various glaucoma surgeries and procedures in Medicare beneficiaries from 1994 to 2012. Ophthalmology. 2015;122(8):1615–24.

    Article  Google Scholar 

  13. Ma AK, Lee JH, Warren JL, Teng CC. GlaucoMap—distribution of glaucoma surgical procedures in the United States. Clin Ophthalmol. 2020;14:2551–60.

    Article  Google Scholar 

  14. Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a Survey of the American Glaucoma Society. J Glaucoma. 2017;26(8):687–93.

    Article  Google Scholar 

  15. Molteno AC, Straughan JL, Ancker E. Long tube implants in the management of glaucoma. S Afr Med J. 1976;50(27):1062–6.

    CAS  Google Scholar 

  16. Patel S, Pasquale LR. Glaucoma drainage devices: a review of the past, present, and future. Semin Ophthalmol. 2010;25(5-6):265–70.

    Article  Google Scholar 

  17. Le RM. drainage au irin de la chambre anterieure contre l’hypertonie et al douleur. Rev Gen Ophthalmol. 1906;25:481.

    Google Scholar 

  18. Krupin T, Podos SM, Becker B, Newkirk JB. Valve implants in filtering surgery. Am J Ophthalmol. 1976;81(2):232–5.

    Article  CAS  Google Scholar 

  19. Budenz DL, Barton K, Gedde SJ, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015;122(2):308–16.

    Article  Google Scholar 

  20. Christakis PG, Kalenak JW, Tsai JC, et al. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology. 2016;123(10):2093–102.

    Article  Google Scholar 

  21. Gedde SJ, Panarelli JF, Banitt MR, Lee RK. Evidenced-based comparison of aqueous shunts. Curr Opin Ophthalmol. 2013;24(2):87–95.

    Article  Google Scholar 

  22. Minckler DS, Heuer DK, Hasty B, Baerveldt G, Cutting RC, Barlow WE. Clinical experience with the single-plate Molteno implant in complicated glaucomas. Ophthalmology. 1988;95(9):1181–8.

    Article  CAS  Google Scholar 

  23. Molteno AC, Van Rooyen MM, Bartholomew RS. Implants for draining neovascular glaucoma. Br J Ophthalmol. 1977;61(2):120–5.

    Article  CAS  Google Scholar 

  24. Lloyd MA, Sedlak T, Heuer DK, et al. Clinical experience with the single-plate Molteno implant in complicated glaucomas. Update of a pilot study. Ophthalmology. 1992;99(5):679–87.

    Article  CAS  Google Scholar 

  25. Ancker E, Molteno AC. Molteno drainage implant for neovascular glaucoma. Trans Ophthalmol Soc U K. 1982;102(Pt 1):122–4.

    Google Scholar 

  26. Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology. 1996;103(2):299–305.

    Article  CAS  Google Scholar 

  27. Freedman J, Rubin B. Molteno implants as a treatment for refractory glaucoma in black patients. Arch Ophthalmol. 1991;109(10):1417–20.

    Article  CAS  Google Scholar 

  28. Every SG, Molteno AC, Bevin TH, Herbison P. Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol. 2006;124(3):355–60.

    Article  Google Scholar 

  29. Schocket SS, Lakhanpal V, Richards RD. Anterior chamber tube shunt to an encircling band in the treatment of neovascular glaucoma. Ophthalmology. 1982;89(10):1188–94.

    Article  CAS  Google Scholar 

  30. Gedde SJ. Management of glaucoma after retinal detachment surgery. Curr Opin Ophthalmol. 2002;13(2):103–9.

    Article  Google Scholar 

  31. Kornmann HL, Gedde SJ. Glaucoma management after vitreoretinal surgeries. Curr Opin Ophthalmol. 2016;27(2):125–31.

    Article  Google Scholar 

  32. Omi CA, De Almeida GV, Cohen R, Mandia C Jr, Kwitko S. Modified Schocket implant for refractory glaucoma. Experience of 55 cases. Ophthalmology. 1991;98(2):211–4.

    Article  CAS  Google Scholar 

  33. Krupin T, Kaufman P, Mandell A, et al. Filtering valve implant surgery for eyes wtih neovascular glaucoma. Am J Ophthalmol. 1980;89(3):338–43.

    Article  CAS  Google Scholar 

  34. Folberg R, Hargett NA, Weaver JE, McLean IW. Filtering valve implant for neovascular glaucoma in proliferative diabetic retinopathy. Ophthalmology. 1982;89(3):286–9.

    Article  CAS  Google Scholar 

  35. Molteno AC, Ancker E, Van Biljon G. Surgical technique for advanced juvenile glaucoma. Arch Ophthalmol. 1984;102(1):51–7.

    Article  CAS  Google Scholar 

  36. Krupin T, Kaufman P, Mandell AI, et al. Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma. Am J Ophthalmol. 1983;95(6):775–82.

    Article  CAS  Google Scholar 

  37. Herschler J, Agness D. A modified filtering operation for neovascular glaucoma. Arch Ophthalmol. 1979;97(12):2339–41.

    Article  CAS  Google Scholar 

  38. Sinclair SH, Aaberg TM, Meredith TA. A pars plana filtering procedure combined with lensectomy and vitrectomy for neovascular for neovascular glaucoma. Am J Ophthalmol. 1982;93(2):185–91.

    Article  CAS  Google Scholar 

  39. Schocket SS, Nirankari VS, Lakhanpal V, Richards RD, Lerner BC. Anterior chamber tube shunt to an encircling band in the treatment of neovascular glaucoma and other refractory glaucomas. A long-term study. Ophthalmology. 1985;92(4):553–62.

    Article  CAS  Google Scholar 

  40. Lloyd MA, Baerveldt G, Heuer DK, Minckler DS, Martone JF. Initial clinical experience with the Baerveldt implant in complicated glaucomas. Ophthalmology. 1994;101(4):640–50.

    Article  CAS  Google Scholar 

  41. Siegner SW, Netland PA, Urban RC Jr, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology. 1995;102(9):1298–307.

    Article  CAS  Google Scholar 

  42. Shalaby WS, Myers JS, Razeghinejad R, Katz LJ, Pro M, Dale E, Fudemberg SJ, Mantravadi AV, Shukla AG. Outcomes of valved and nonvalved tube Shunts in neovascular glaucoma. Ophthalmol Glaucoma. 2021;4(2):182–192. https://doi.org/10.1016/j.ogla.2020.09.010. Epub 2020 Sep 18. PMID: 32956898.

  43. New World Medical. Ahmed ClearPath®. https://www.newworldmedical.com/ahmed-clearpath/. Published 2019. Accessed 2021.

  44. Krupin T, Ritch R, Camras CB, et al. A long Krupin-Denver valve implant attached to a 180 degrees scleral explant for glaucoma surgery. Ophthalmology. 1988;95(9):1174–80.

    Article  CAS  Google Scholar 

  45. Mastropasqua L, Carpineto P, Ciancaglini M, Zuppardi E. Long-term results of Krupin-Denver valve implants in filtering surgery for neovascular glaucoma. Ophthalmologica. 1996;210(4):203–6.

    Article  CAS  Google Scholar 

  46. Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995;120(1):23–31.

    Article  CAS  Google Scholar 

  47. Coleman AL, Wilson MR, Tam M, et al. Initial clinical experience with the Ahmed glaucoma valve implant—correction. Am J Ophthalmol. 1995;120(5):684.

    Article  CAS  Google Scholar 

  48. Christakis PG, Zhang D, Budenz DL, et al. Five-year pooled data analysis of the Ahmed Baerveldt Comparison Study and the Ahmed versus Baerveldt Study. Am J Ophthalmol. 2017;176:118–26.

    Article  Google Scholar 

  49. Tsai JC, Johnson CC, Kammer JA, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology. 2006;113(6):913–7.

    Article  Google Scholar 

  50. Pakravan M, Rad SS, Yazdani S, Ghahari E, Yaseri M. Effect of early treatment with aqueous suppressants on Ahmed glaucoma valve implantation outcomes. Ophthalmology. 2014;121(9):1693–8.

    Article  Google Scholar 

  51. Zhou M, Wang W, Huang W, Zhang X. Use of mitomycin C to reduce the incidence of encapsulated cysts following Ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. BMC Ophthalmol. 2014;14:107.

    Article  Google Scholar 

  52. Yazdani S, Doozandeh A, Pakravan M, Ownagh V, Yaseri M. Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial. Eur J Ophthalmol. 2017;27(4):411–6.

    Article  Google Scholar 

  53. Eid TM, Radwan A, el-Manawy W, el-Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol. 2009;44(4):451–6.

    Article  Google Scholar 

  54. Zhou M, Xu X, Zhang X, Sun X. Clinical outcomes of Ahmed glaucoma valve implantation with or without intravitreal bevacizumab pretreatment for neovascular glaucoma: a systematic review and meta-analysis. J Glaucoma. 2016;25(7):551–7.

    Article  Google Scholar 

  55. Hwang HB, Han JW, Yim HB, Lee NY. Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review. J Ocul Pharmacol Ther. 2015;31(4):198–203.

    Article  CAS  Google Scholar 

  56. Mahdy RA, Nada WM, Fawzy KM, Alnashar HY, Almosalamy SM. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma. J Glaucoma. 2013;22(9):768–72.

    Article  Google Scholar 

  57. Arcieri ES, Paula JS, Jorge R, et al. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up. Acta Ophthalmol. 2015;93(1):e1−6.

    Google Scholar 

  58. Sahyoun M, Azar G, Khoueir Z, et al. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma. J Glaucoma. 2015;24(5):383–8.

    Article  Google Scholar 

  59. Lubinski W, Krzystolik K, Goslawski W, Kuprjanowicz L, Mularczyk M. Comparison of polypropylene and silicone Ahmed(R) glaucoma valves in the treatment of neovascular glaucoma: a 2-year follow-up. Adv Clin Exp Med. 2018;27(1):15–20.

    Article  Google Scholar 

  60. Gedde SJ, Feuer WJ, Lim KS, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology. 2020;127(3):333–45.

    Article  Google Scholar 

  61. Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–814 e801.

    Article  Google Scholar 

  62. Owen CG, Newsom RS, Rudnicka AR, Ellis TJ, Woodward EG. Vascular response of the bulbar conjunctiva to diabetes and elevated blood pressure. Ophthalmology. 2005;112(10):1801–8.

    Article  Google Scholar 

  63. Koval MS, El Sayyad FF, Bell NP, et al. Risk factors for tube shunt exposure: a matched case-control study. J Ophthalmol. 2013;2013:196215.

    Google Scholar 

  64. Chaku M, Netland PA, Ishida K, Rhee DJ. Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery. Clin Ophthalmol. 2016;10:547–53.

    Google Scholar 

  65. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1976;81(4):383–96.

    Google Scholar 

  66. Hayreh SS, Klugman MR, Podhajsky P, Servais GE, Perkins ES. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol. 1990;228(4):281–96.

    Article  CAS  Google Scholar 

  67. Mason JO 3rd, Albert MA Jr, Mays A, Vail R. Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina. 2006;26(7):839–41.

    Article  Google Scholar 

  68. Kim LA, D'Amore PA. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol. 2012;181(2):376–9.

    Article  Google Scholar 

  69. Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 2008;28(5):696–702.

    Article  Google Scholar 

  70. Eslami Y, Mohammadi M, Fakhraie G, Zarei R, Moghimi S. Ahmed glaucoma valve implantation with tube insertion through the ciliary sulcus in pseudophakic/aphakic eyes. J Glaucoma. 2014;23(2):115–8.

    Article  Google Scholar 

  71. Moon K, Kim YC, Kim KS. Ciliary sulcus Ahmed valve implantation. Korean J Ophthalmol. 2007;21(2):127–30.

    Article  Google Scholar 

  72. Rush R. Ciliary sulcus Ahmed glaucoma valve tube placement in neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2009;40(5):489–92.

    Article  Google Scholar 

  73. Luttrull JK, Avery RL, Baerveldt G, Easley KA. Initial experience with pneumatically stented Baerveldt implant modified for pars plana insertion for complicated glaucoma. Ophthalmology. 2000;107(1):143–9. discussion 149−150.

    Article  CAS  Google Scholar 

  74. Wallsh JO, Gallemore RP, Taban M, Hu C, Sharareh B. Pars plana Ahmed valve and vitrectomy in patients with glaucoma associated with posterior segment disease. Retina. 2013;33(10):2059–68.

    Article  Google Scholar 

  75. Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, Riazi-Esfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38(4):292–300.

    Article  Google Scholar 

  76. Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789–803 e782.

    Article  Google Scholar 

  77. Shah AA, WuDunn D, Cantor LB. Shunt revision versus additional tube shunt implantation after failed tube shunt surgery in refractory glaucoma. Am J Ophthalmol. 2000;129(4):455–60.

    Article  CAS  Google Scholar 

  78. Ness PJ, Khaimi MA, Feldman RM, et al. Intermediate term safety and efficacy of transscleral cyclophotocoagulation after tube shunt failure. J Glaucoma. 2012;21(2):83–8.

    Google Scholar 

  79. Semchyshyn TM, Tsai JC, Joos KM. Supplemental transscleral diode laser cyclophotocoagulation after aqueous shunt placement in refractory glaucoma. Ophthalmology. 2002;109(6):1078–84.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA

    Wesam S. Shalaby, Dilru C. Amarasekera & Aakriti Garg Shukla

  2. Tanta Medical School, Tanta University, Tanta, Gharbia, Egypt

    Wesam S. Shalaby

Authors
  1. Wesam S. Shalaby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dilru C. Amarasekera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aakriti Garg Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aakriti Garg Shukla .

Editor information

Editors and Affiliations

  1. Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA

    Mary Qiu

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shalaby, W.S., Amarasekera, D.C., Shukla, A.G. (2022). Aqueous Shunt for Neovascular Glaucoma. In: Qiu, M. (eds) Neovascular Glaucoma. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-031-11720-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-11720-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-11719-0

  • Online ISBN: 978-3-031-11720-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation